SLSN Q1 2026 Earnings Narrowing Loss Amid Transition PNBK Q1 2019 Earnings Significant EPS Miss Amid Challenging Banking Environment CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses MSN Q1 2024 Earnings Loss Reported as Stock Surges Over 20 POET Q1 2026 Earnings EPS Misses Expectations as Revenue Remains Unreported